Patient's perception of medication and nonadherence to chronic disease treatments. A population-based study in Brazil

被引:1
作者
da Silva Menolli, Poliana Vieira [1 ]
Ivama Brummel, Adriana Mitsue [2 ,3 ]
Guidoni, Camilo Molino [4 ]
Girotto, Edmarlon [4 ]
机构
[1] Western Parana State Univ UNIOESTE, Ctr Med & Pharmaceut Sci, Cascavel, Brazil
[2] London Sch Econ & Polit Sci LSE, Dept Hlth Policy, London, England
[3] Brazilian Hlth Regulatory Agcy Anvisa, Hlth Regulatory Expert, Brasilia, DF, Brazil
[4] State Univ Londrina UEL, Postgrad Program Publ Hlth, Londrina, Parana, Brazil
关键词
medicines; medication adherence; chronic disease; hypertension; diabetes and dyslipidemia; DRUG-THERAPY; ADHERENCE; HYPERTENSION; BELIEFS; PREVALENCE; ILLNESS; ADULTS;
D O I
10.1093/jphsr/rmae001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To identify the association between patients' perception of medication for hypertension, diabetes, and dyslipidemia and nonadherence by regions of Brazil.Methods: This is a cross-sectional study using open data from the urban population-based survey National Survey on Access, Use and Promotion of Rational Use of Medicines in Brazil (PNAUM), conducted from September 2013 to February 2014. Patients' self-reported perceptions recorded on each of the medicines for hypertension, diabetes, and dyslipidaemia were used for analysis. The dependent variable was nonadherence to treatment, and the patient's perceptions about medication were the independent variable. Logistic regression was performed to calculate the crude and adjusted odds ratios.Key findings: Nonadherence was observed in 6.6% of the 16 491 drugs, with missed doses (84.5%) being the main cause. In the adjusted analysis, perception of medication effectiveness considered regular or poor (OR 3.025; 95% CI 1.672-5.473), perception that caused discomfort (OR 2.731; 95% CI 1.464-5.092), and medicines used for <6 months (OR 1.557; 95% CI 1.089-2.227) had higher chances of nonadherence in Brazil (all regions).Conclusion: Patient perception of the effectiveness, safety, and time of use of medications are key factors associated with nonadherence and can contribute to building medication beliefs that may affect current and future adherence.
引用
收藏
页数:10
相关论文
共 60 条
[1]  
[Anonymous], 2003, ADHERENCE LONG TERM
[2]   Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study [J].
Balkrishnan, R ;
Rajagopalan, R ;
Camacho, FT ;
Huston, SA ;
Murray, FT ;
Anderson, RT .
CLINICAL THERAPEUTICS, 2003, 25 (11) :2958-2971
[3]   Factors associated with adherence to drug therapy:: a population-based study [J].
Bardel, Annika ;
Wallander, Mari-Ann ;
Svardsudd, Kurt .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) :307-314
[4]  
Ben Angela Jornada, 2012, Rev. Saúde Pública, V46, P279
[5]  
Brasil, 2002, PLANO REORGANIZA O A
[6]  
Brasil. Ministerio da Saude, 2020, RELA O NACL MEDICAME
[7]  
Brasil. Ministerio da Saude. Secretaria de Ciencia T e IE, 2014, PNAUM MICRODADOS MED
[8]   Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences [J].
Chowdhury, Rajiv ;
Khan, Hassan ;
Heydon, Emma ;
Shroufi, Amir ;
Fahimi, Saman ;
Moore, Carmel ;
Stricker, Bruno ;
Mendis, Shanthi ;
Hofman, Albert ;
Mant, Jonathan ;
Franco, Oscar H. .
EUROPEAN HEART JOURNAL, 2013, 34 (38) :2940-2948
[9]   Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study [J].
Cooper, Vanessa ;
Metcalf, Leanne ;
Versnel, Jenny ;
Upton, Jane ;
Walker, Samantha ;
Horne, Rob .
NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2015, 25
[10]   Economic impact of medication non-adherence by disease groups: a systematic review [J].
Cutler, Rachelle Louise ;
Fernandez-Llimos, Fernando ;
Frommer, Michael ;
Benrimoj, Charlie ;
Garcia-Cardenas, Victoria .
BMJ OPEN, 2018, 8 (01)